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Introduction: There is a wide variation in the lung cancer resection 
rate in England. We assessed the effect of the regional provision of 
thoracic surgery service on the variation in lung cancer resection rate.
Methods: A retrospective observational study correlating National 
Lung Cancer Audit data with thoracic surgery workforce data was 
performed to review the lung cancer resection rate in England in 
2008 and 2009.
Results: In 2008, there was a sixfold variation in resection rate, 
with a higher resection rate in hospitals where surgeons were based 
(base hospitals) than in peripheral hospitals (20.0% versus 11.6%, 
p < 0.001). The resection rate was also higher in cancer networks, 
which were served by two or more specialist thoracic surgeons 
(14.6% versus 12.7%, p = 0.028), and where surgeons were present 
in more than two-thirds of the lung cancer multidisciplinary team 
meetings (14.4% versus 12.0%, p = 0.046). In 2009, the overall 
resection rate increased from 14.5% to 18.4%. Four units increased 
their number of specialist thoracic surgeons and had a significantly 
higher increase in resection rate than units without expansion (relative 
rise 66.3% versus 19.2%; p = 0.022).
Conclusions: The large variation in the resection rate seems, in part, 
to be related to the local availability of specialist thoracic surgeons. 
The greatest improvement in the resection rate was in units with 
expansion of specialist thoracic surgeons. We suggest the expan-
sion of specialist thoracic surgeons will improve the resection rate 
and thereby the overall survival of lung cancer in England. This has 
significant implications for the future of training in cardiothoracic 
surgery and organization of cancer services.
Key Words: Non–small-lung cancer, Resection rates, Thoracic 
surgeon.
(J Thorac Oncol. 2013;8: 68–72)
Lung cancer is the leading cause of cancer death in the United Kingdom. Despite the ambitions of the National Health 
Service Cancer Plan for England in 20001 to bring cancer sur-
vival up to the level of the best countries by 2010, the United 
Kingdom continues to have the poorest lung cancer survival 
among developed nations.2 Patients who undergo curative resec-
tion have the best chance of long-term survival, and there is 
evidence from the United Kingdom linking higher resection 
rates with better survival rates.3 Therefore, it is not surprising 
that the lung cancer resection rate in the United Kingdom has 
been significantly below that of most other countries.4,5 This was 
recognized by the British Thoracic Society and the Society of 
Cardiothoracic Surgeons, whose recommendations included 
the increased provision of thoracic surgeons.6 The number of 
lung resections for primary cancer in the United Kingdom and 
Ireland as identified by the Society for Cardiothoracic Surgery 
(SCTS) register increased from 3112 in 2001-2002 to 5265 in 
2009-2010. This represented an increase in resections of almost 
60%, with a reduction in the operative mortality for lung cancer 
resections from 3.8% to 2.1%.7 Although the resection rate in 
England has improved over the years, it remains below that of 
the United States and many parts of Europe.8
Within the United Kingdom, the geographical 
variation in lung cancer resection rate is even more striking, 
despite adjusting for case-mix factors including age, stage, 
performance status and socioeconomic status,8 there is 
a threefold variation in survival and sixfold variation in 
resection rate depending on where one lives. Data from the 
National Lung Cancer Audit have also been used to analyze 
resection rates by characteristics of treatment center. Rich 
et al.9 have demonstrated a more than 50% higher resection 
rate for patients who were first seen in a center that has 
cardiothoracic surgery on site after adjusting for the Charlson 
comorbidity index and the case-mix factors mentioned above. 
The aim of the study was to test the hypothesis that resection 
rate is limited by the availability of specialist thoracic surgeons 
and explore how the variation of the resection rate is related to 
the characteristics of the surgical workforce.
MATERIALS AND METHODS
Lung Cancer Service Organization
Secondary care lung cancer services in the NHS in 
England were delivered through 159 acute hospital trusts 
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during the period of study. For the purpose of cancer services, 
these trusts were organized into 28 cancer networks. Thirty-
two hospital trusts (hereafter referred to as base hospitals) 
provided lung cancer surgery through both cardiothoracic 
surgeons and specialist thoracic surgeons. Apart from serv-
ing their own specialist teams, the base hospitals provided 
surgical support to the lung cancer multidisciplinary teams 
(MDTs) of the surrounding peripheral hospitals, where they 
also held outpa tient clinics. Lung cancer MDTs in the United 
Kingdom currently comprises thoracic surgeons, respiratory 
physicians, radiologists, oncologists, pathologists, lung cancer 
nurse specialists, and palliative care clinicians.
National Lung Cancer Audit Database
The National Lung Cancer Audit is a register of newly 
diagnosed lung cancer patients, processes, and outcomes in 
the United Kingdom. It is jointly run by the Royal College of 
Physicians and the Information Centre for Health and Social 
Care. The first full year of data collection was 2005; this data 
set contained 112 fields, covering patient demographics, clini-
copathologic and process-of-care variables. In 2008, all but 
three hospital trusts and all cancer networks participated and 
submitted their data to the audit. The database captured 94% 
of expected lung cancer cases presenting to secondary care. By 
2009, all but one hospital trust participated, and the database 
is believed to have captured almost all lung cancer cases pre-
senting to secondary care. Histological diagnosis was pursued 
in patients who were fit to undergo treatment on the basis of 
performance status and fitness, whereas frail and unfit patients 
were coded as lung cancer on the basis of clinicoradiological 
correla tion, by the MDT. We adopted the definition of resec-
tion rate as the number of patients undergoing surgical resection 
out of those with histologically confirmed non–small-cell lung 
cancer (NSCLC) patients. This definition allows standardized 
comparison with published data from the United States and 
Europe.10
U.K. Cardiothoracic Surgery Workforce Data
Manpower data for cardiothoracic surgery was obtained 
from the Specialist Advisory Committee, the SCTS, and the 
Center for Workforce Intelligence. Cardiothoracic surgeons 
were defined as those surgeons whose practice comprised of 
both cardiac and thoracic surgery. Surgeons were considered 
to be specialist thoracic surgeons if their practice included 
only thoracic (noncardiac) surgery.
Data on the surgical attendance at MDT was obtained 
through the peer review process of the MDTs.11 We correlated 
the resection rate in England during the audit periods of 2008–
2009 with manpower data from this period. We investigated 
whether resection rate was related to the following variables: 
caseload of the trust, the availability of surgeons as a whole 
and in particular specialist thoracic surgeons, their attendance 
at lung MDTs, and the effects of increasing the number of spe-
cialist thoracic surgeons in the workforce.
Statistical Methods
Statistical analysis was carried out with SPSS version 
16.0 (SPSS, Chicago, IL). Correlations between nonparametric 
continuous variables were evaluated with Pearson’s correla-
tion coefficient. Nonparametric variables are expressed as 
median (interquartile range). Significance of intergroup dif-
ference was evaluated in nonparametric variables by the 
Mann–Whitney U test and Wilcoxon sign-ranked tests, with 
the exact method.
RESULTS
Resection Rate
In England, in 2008, there were 21,586 cases of lung 
cancer (excluding histologically confirmed cases of small-cell 
lung cancer). Of these, 14,662 cases were histologically con-
firmed NSCLC whereas the remainder were clinical diagno-
ses. Among these, 2123 patients (14.5%) underwent surgery 
with curative intent. In 2009, the number of recorded cases 
increased to 25,029. Of these, 17,948 cases were histologi-
cally confirmed NSCLC, and 3308 patients (18.4%) under-
went surgery with curative intent. This represented a 56% 
increase in the number of resections and a 26.9% increase in 
the resection rate.
Effect of Caseload
We correlated the number of NSCLC cases recorded 
with the resection rate for each trust. There was no correlation 
between caseload and resection rate (r = 0.017) (Fig. 1).
Effects of Availability of Thoracic Surgery
The resection rates were found to be higher in patients 
seen in base hospital trusts than in peripheral trusts (base 
 hospital resection rate 20% (interquartile range [IQR] 13.8%-
21.6%) versus peripheral hospitals 11.6% (7.9%-17.5%), 
p < 0.001 (Table 1).
Despite being served by the same surgical team, the 
resection rate was higher for lung MDTs in the base hospitals 
FIGURE 1.  The effect of volume and resection rates across 
England. Units with higher volume did not have a corre-
sponding higher resection rate.
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than for MDTs in their respective peripheral hospitals (median 
resection rate for base hospital 18.5% (IQR 15.6%-21.6%) 
versus peripheral hospitals 13.2% (7.6%-16.1%, p < 0.001) 
(Table 2).
Of the 32 base hospitals, 18 had one or no special-
ist thoracic surgeons, whereas 14 had two or more specialist 
thoracic surgeons. Networks served by two or more special-
ist thoracic surgeons performed more operations for NSCLC 
than the remainder (median 116 (IQR 61-167) versus 62 (41-
84), p = 0.011). They also had a higher resection rate (median 
14.6% (IQR 13.3%-16.8%) versus 12.7% (9.1%-14.9%), 
p = 0.028, (Table 3)).
Data on surgical attendances at MDT were obtained for 
132 (83%) trusts. Of these MDTs, surgeons (cardiothoracic 
or specialist thoracic) were present in more than two-thirds of 
the meetings in 71 trusts (53.6%). These trusts had a higher 
resection rate than those where surgeons were present in less 
than two-thirds of the meetings (median 14.4% [IRQ, 9.1%–
21.6%] versus 12.0% [9.0%–18.1%], p = 0.046).
Effect of Increasing Thoracic Surgical Capacity
In 2009, four base hospitals appointed additional spe-
cialist thoracic surgeons. MDTs served by these units experi-
enced a larger growth in surgical activity than in the remainder 
(median growth in number of resections 96.4% versus 42.3%, 
p = 0.06). The resection rate also rose significantly more in 
the networks they served (median relative rise in resection 
rate 66.3% [interquartile range, 39.5%–91.3%], versus 19.2% 
[interquartile range, 4.2%–48.8%], p = 0.022).
DISCUSSION
Principal Findings
We found no correlation between resection rate and 
local caseload—busy units did not necessarily have higher 
rates. The lung cancer resection rate was however associated 
both with the accessibility to and the provision of special-
ist thoracic surgeons. The presence of a surgeon at the lung 
MDT, where the management of all new lung cancer cases is 
discussed, is imperative. It is no coincidence that the resec-
tion rates are higher in the base hospitals as these are invari-
ably well attended by the surgeons who work in these units. 
When those surgeons are able to attend regularly at MDTs 
in  peripheral hospitals, their resection rates also increase as 
a consequence. The provision of specialist thoracic surgeons 
provided an even greater boost to the resection rate. Rates were 
already higher where two or more thoracic surgical specialists 
served a network and an even greater increase was seen when 
new specialists were employed.
Comparison with Other Studies
Previous reports have found that the implementation 
of central referral pathways and MDTs boosted the resec-
tion rate substantially to over 20% within a short period of 
time.12–15 However, the U.K. resection rate has improved8 but 
still remains lower than many other countries, despite having 
universally established the MDT approach as a standard pro-
cedure. This study has demonstrated that it is the constitution 
rather than just the existence of a lung cancer MDT, which is 
important.
Our findings of a higher resection rate in base or sur-
gical centers than in peripheral or nonsurgical centers echo 
those of Rich et al.9 The authors found that a patient first seen 
at a base hospital was 51% more likely to undergo surgery 
than if they were first seen at a peripheral hospital, a figure 
adjusted for a range of case-mix factors including age, stage, 
and comorbidity. They did not identify what features of a sur-
gical center drove the increase in resection rate, nor did they 
differentiate between the presence of cardiothoracic and spe-
cialist thoracic surgeons. 
We have previously shown that the resection rate of a 
unit could be doubled with the addition of a specialist tho-
racic surgeon.15 In that series, the increase was attributed 
to more surgery in older, higher-risk patients facilitated by 
the increased use of more specialized techniques, that is, 
video-assisted thoracic surgery lobectomy and sleeve resec-
tion. These findings could be extrapolated across England to 
account for the variation in the resection rates between centers 
with specialist thoracic surgeons and a higher resection rate 
and other centers.
There is already evidence that a change in attitude 
toward the operative risk versus benefit ratio is pushing the 
resection rate up.8 However, there is still room for improve-
ment nationally as there is evidence that the elderly female 
population is less likely to get histocytological confirmation 
and anticancer treatment.16 Such variation could account for 
TABLE 1.  Effect of Local Availability of Thoracic Services–
Comparison of all Base and All Peripheral Units across 
England
Base  
Hospitals %
Peripheral  
Hospitals %
p
Resection rates: median 
(interquartile range)
20 (13.8–21.6) 11.6 (7.9–17.5) <0.001
TABLE 2.  Effect of Local Availability of Thoracic Services–
Comparison of Resection Rates of Base versus Peripheral Units 
Matched within Each Network
Base  
Hospital %
Peripheral  
Hospital %
p
Resection rate within 
each network: median 
(interquartile range)
18.5 (15.6–21.6) 13.2 (7.6–16.1) <0.001
TABLE 3.  Effect of Number of Specialist Thoracic Surgeons 
on the Workload of Each Network
≥ 2 Specialist 
Thoracic  
Surgeons
≤ 1 Specialist 
Thoracic  
Surgeon
p
Number of operations median 
(interquartile range)
116 (61–167) 62 (41–84) 0.011
Resection rate median 
(interquartile range)
14.6%  
(13.3%–16.8%)
12.7%  
(9.1% –14.9%)
0.028
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differences in resection rates between centers with specialist 
thoracic surgeons and other centers. 
Our results raise the possibility that the availability 
of thoracic surgical manpower is the main limiting 
factor for resection rate. Manpower data from countries 
with higher resection rates support this. In England and 
Wales there are approximately 67 thoracic specialists 
and 63 cardiothoracic surgeons (Centre for Workforce 
Intelligence, 2010) offering approximately 90 whole-
time equivalents or 1:700,000 population. The U.S. 
coverage is 1:100,000,17 which is an underestimate as it 
excludes general surgeons who also regularly undertake 
lung resections there. The coverage in Canada lies 
between 1:150,000 and 1:500,000,18 whereas in Australia 
it is 1:250,000.19 This suggests a stark underprovision of 
thoracic surgery in the United Kingdom.
One solution would be to centralize services to consoli-
date the greater experience and expertise of thoracic surgical 
specialists.9 Indeed, there has been a small reduction in the 
number of MDTs in England, from 175 in 2006, to 158 in 
2011.11 However, this could be disadvantageous to the more 
outlying centers and may actually increase geographical varia-
tion and inequality. There is evidence that socially disadvan-
taged patients who live further from specialist centers have 
lower treatment rates.20 An alternative would be to continue 
to increase thoracic surgical specialist appointments, which 
would increase attendance at peripheral hospital MDTs, 
which our results predict, would lead to an increase in local 
resection rate.
Strengths and Limitations of the Study
This study is a comprehensive and unselected analysis 
of lung cancer surgery at a national level, and the findings 
should contribute to the elimination of stark health inequali-
ties. There are a number of limitations to this study. First, the 
use of a resection rate, where the denominator is histologically 
confirmed NSCLC, is affected by how aggressive the local 
policy is to obtain tissue diagnosis. Previously, histology was 
only pursued if radical treatment was anticipated. However, 
with the advent of tailored biological therapies, tissue diagno-
sis is increasingly undertaken, even for treatments with pal-
liative intent. This may have an effect on the denominator for 
resection rate, which could confound comparisons across dif-
ferent practices. Second, information on the reasons for non-
operation in areas with a low resection rate was not assessed. 
An understanding of regional variations in socioeconomic 
status and comorbidities would help to better plan the future 
investment in thoracic surgery.
Conclusion and Implications
We have demonstrated the link between the acknowl-
edged geographical variations in the lung cancer resection rate 
in England and the local provision of specialist thoracic sur-
gery. When considered in conjunction with the recent study3 
that has demonstrated a lower risk of death from lung cancer in 
populations with a higher surgical resection rate, these results 
have important implications for other health care systems. 
National strategies for lung cancer should focus on improving 
the resection rate by investing in the provision and training of 
specialist thoracic surgery.
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